These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9797850)

  • 1. Effect of corticotrophin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease.
    Colao A; Pivonello R; Ferone D; Faggiano A; Facciolli G; Di Somma C; Boudouresque F; Oliver C; Lombardi G
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):77-84. PubMed ID: 9797850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease.
    Colao A; Ferone D; Di Sarno A; Tripodi FS; Cerbone G; Marzullo P; Boudouresque F; Oliver C; Merola B; Lombardi G
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):157-66. PubMed ID: 8881447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.
    Colao A; Pivonello R; Ferone D; La Tessa G; Faggiano A; Facciolli G; Di Somma C; Merola B; Lombardi G
    J Endocrinol Invest; 1998 Apr; 21(4):257-62. PubMed ID: 9624601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferior petrosal sinus AVP in patients with Cushing's syndrome.
    Yanovski JA; Friedman TC; Nieman LK; Chrousos GP; Cutler GB; Doppman JL; Kalogeras KT
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):199-206. PubMed ID: 9302395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's disease.
    Friedman TC; Yanovski JA; Nieman LK; Doppman JL; Cutler GB; Oldfield EH; Gold PM; Chrousos GP; Kalogeras KT
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3068-72. PubMed ID: 8768876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
    Korbonits M; Trainer PJ; Edwards R; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):29-35. PubMed ID: 7641409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotrophin releasing hormone (CRH1-41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors: evidence from petrosal sinus sampling in man.
    Nussey SS; Page SR; Peterson DB; Byrne J; Crosby SR; White A; Ang VT; Jackson R; Jenkins JS
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):51-6. PubMed ID: 1848486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to vasopressin action on the kidney in patients with Cushing's disease.
    Knoepfelmacher M; Pradal MJ; Dio RD; Salgado LR; Semer M; Wajchenberg BL; Liberman B
    Eur J Endocrinol; 1997 Aug; 137(2):162-6. PubMed ID: 9272104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M; Corcuff JB; Roger P; Tabarin A
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.